Cargando…
Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
Neuroendocrine differentiation (NED) of prostate cancer represents an acknowledged predictor of resistant and more aggressive disease. NED can be functionally exploited in vivo using PET/CT imaging with somatostatin analogs radiolabeled with 68Ga. Many previous reports have shown that 18F-FDG PET/CT...
Autores principales: | Bauckneht, Matteo, Morbelli, Silvia, Miceli, Alberto, Rebuzzi, Sara Elena, Fornarini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998830/ https://www.ncbi.nlm.nih.gov/pubmed/33800158 http://dx.doi.org/10.3390/diagnostics11030468 |
Ejemplares similares
-
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT
por: Gandini, Annalice, et al.
Publicado: (2023) -
Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on (18)F-FDG PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023) -
Mesonephric Adenocarcinoma of the Uterine Fundus Exhibiting High (18)F-FDG Uptake
por: Kim, Hyung Kyung, et al.
Publicado: (2020) -
Incidental (18)F-FDG Uptake of the Pubic Ramus and Abdominal Muscles due to Athletic Pubalgia During Acute Prostatitis
por: Rager, Olivier, et al.
Publicado: (2018) -
Beyond the Prognostic Value of 2-[(18)F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management
por: Borea, Roberto, et al.
Publicado: (2022)